These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15830178)

  • 1. Clinical significance of the physicochemical properties of LDL in type 2 diabetes.
    Scheffer PG; Teerlink T; Heine RJ
    Diabetologia; 2005 May; 48(5):808-16. PubMed ID: 15830178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus.
    Lewis GF; Steiner G
    Diabetes Metab Rev; 1996 Apr; 12(1):37-56. PubMed ID: 8861500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Susceptibility of LDL to lipid peroxidation in non-insulin-dependent diabetes mellitus with or without macroangiopathy].
    Gallou G; Ruelland A; Campion L; Allannic H; Legras B; Cloarec L
    Ann Biol Clin (Paris); 1994; 52(10):695-9. PubMed ID: 7747876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid modification in type 2 diabetes: the role of LDL and HDL.
    Vergès B
    Fundam Clin Pharmacol; 2009 Dec; 23(6):681-5. PubMed ID: 19650852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very low density lipoproteins in type II diabetes mellitus and risk of atherosclerosis.
    Schwandt P
    Horm Metab Res Suppl; 1985; 15():80-3. PubMed ID: 3865885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes.
    Vakkilainen J; Steiner G; Ansquer JC; Perttunen-Nio H; Taskinen MR
    Diabetes Care; 2002 Mar; 25(3):627-8. PubMed ID: 11874962
    [No Abstract]   [Full Text] [Related]  

  • 8. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
    Rizzo M; Berneis K; Altinova AE; Toruner FB; Akturk M; Ayvaz G; Rini GB; Spinas GA; Arslan M
    Diabet Med; 2008 Dec; 25(12):1406-11. PubMed ID: 19046238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between insulin resistance and small, dense lipoproteins with low density and the development of atherosclerosis in type 2 diabetes mellitus].
    Fábryová L; Cagán S
    Bratisl Lek Listy; 1998; 99(3-4):138-45. PubMed ID: 9919742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics].
    Calvo C
    Rev Med Chil; 1997 Apr; 125(4):460-5. PubMed ID: 9460289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of type 2 diabetes on various electrophoretic characteristics of low-density lipoprotein particles in women.
    Blackburn P; Lemieux I; Lamarche B; Bergeron J; Perron P; Tremblay G; Gaudet D; Després JP
    Diabetologia; 2004 Dec; 47(12):2114-7. PubMed ID: 15602652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients.
    Galland F; Duvillard L; Petit JM; Lagrost L; Vaillant G; Brun JM; Gambert P; Vergès B
    Diabetes Metab; 2006 Dec; 32(6):625-31. PubMed ID: 17296517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes.
    Scheffer PG; Tushuizen ME; Vermue HP; Schindhelm RK; Rustemeijer C; Diamant M
    Eur J Clin Nutr; 2011 Nov; 65(11):1242-9. PubMed ID: 21712838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome?
    Windler E
    Atheroscler Suppl; 2005 Sep; 6(3):11-4. PubMed ID: 16046281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol.
    Nakhjavani M; Khalilzadeh O; Khajeali L; Esteghamati A; Morteza A; Jamali A; Dadkhahipour S
    Lipids; 2010 Apr; 45(4):321-7. PubMed ID: 20224977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atherogenic properties of sera and low-density lipoproteins in patients with diabetes mellitus].
    Sobenin IA; Tertov VV; Koshinski T; Slavina ES; Dedov II; Orekhov AN
    Kardiologiia; 1991 Oct; 31(10):38-41. PubMed ID: 1753579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages.
    Rosenblat M; Hayek T; Aviram M
    Atherosclerosis; 2006 Aug; 187(2):363-71. PubMed ID: 16226266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.